Page 3 - Les meilleurs doctors traitant la maladie suivante : Cancer du foie stade 2 - TOP -91 des médecins

Le Dr Wolfgang Köstler, professeur d'université, est un oncologue médical distingué qui a contribué à l'élaboration de thérapies ciblées, une stratégie fondamentale pour le traitement de nombreux cancers du foie aujourd'hui.

• Plus de 20 ans d'expérience clinique, académique et de recherche en oncologie
• Chef adjoint de la division clinique d'oncologie de l'Université de médecine de Vienne
• Expertise en thérapie systémique individualisée et en immunothérapie
• Se concentrer sur le développement de biomarqueurs et les stratégies d'oncologie de précision

Le professeur agrégé Tahsin Ozatli est spécialisé dans les cancers du sein, du poumon et du système gastro-intestinal, traitant ses patients à l'hôpital universitaire Istinye Liv.

• Spécialiste en médecine interne avec une expérience dans plusieurs hôpitaux en Turquie
• Oncologue à la clinique d'oncologie d'Ankara et à l'hôpital régional de formation et de recherche d'Erzurum
• Études de médecine à l'université Selcuk de Konya
• Promotion au grade de professeur agrégé en 2016

Le professeur associé Dr Yusuf Acikgoz possède une expertise spécialisée en oncologie médicale, avec une formation à l'Université d'État de l'Ohio et une participation active à des essais cliniques internationaux.

• Participer à des essais de phase III tels que CheckMate-649 et Fortitude-101
• Être membre de l'ASCO et de la Société Turque d'Oncologie Médicale
• Se former en immuno-oncologie via les cours du CECOG à Vienne
• Être certifié en Bonnes Pratiques Cliniques et en Protection des Sujets Humains

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Le professeur associé Babek Tabandeh est un chirurgien expert spécialisé dans le cancer du foie et les techniques mini-invasives. Il pratique des chirurgies hépatiques complexes à l'hôpital Medical Park Göztepe.

• Plus de 25 ans d'expérience en chirurgie générale et oncologique
• Spécialisé en chirurgie mini-invasive pour une meilleure récupération
• Auteur publié de plus de 40 articles scientifiques
• Membre du prestigieux American College of Surgeons
• Également membre de la Liver Transplantation Society

Spécialisé en chirurgie laparoscopique et oncologique avec une formation à l'Université d'Istanbul. Le Dr Al se concentre sur les techniques mini-invasives pour le cancer du foie.

• Être formé en chirurgie laparoscopique avancée à la Faculté de médecine de Cerrahpaşa
• Réaliser des chirurgies bariatriques et anti-reflux laparoscopiques
• Être diplômé de la Faculté de médecine de l'Université Ondokuz Mayıs
• Se spécialiser à la Faculté de médecine de l'KTÜ, hôpital Farabi

Le Dr Ozden apporte plus de 20 ans d'expertise en oncologie, acquise à travers divers rôles cliniques à travers la Turquie.

• Spécialisé en oncologie médicale avec un accent sur le cancer du foie
• Formé à la célèbre faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Vaste expérience en milieu hospitalier privé et universitaire
• Engagement envers des plans de traitement personnalisés pour chaque patient

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Le Dr Auala Hubert dirige le centre de cancérologie gastro-intestinale du centre médical Hadassah, apportant 33 ans d'expertise ciblée en oncologie.

• Spécialisation en oncologie médicale et radiothérapie
• Chef du centre de cancérologie gastro-intestinale à Hadassah
• Certifié en oncologie et radiothérapie
• Membre de la Société israélienne d'oncologie clinique
• Maîtrise de l'anglais et de l'hébreu pour les patients internationaux

Le professeur associé Nail Paksoy est un oncologue médical certifié par l'ESMO à l'hôpital Medipol Bahçelievler, spécialisé dans le cancer du foie et doté d'une vaste expérience en essais cliniques.

• Effectuer un stage de spécialisation à l'Institut d'oncologie de l'Université d'Istanbul
• Agir en tant que sous-investigateur dans 8 essais cliniques internationaux en oncologie
• Publier de nombreuses études sur l'efficacité des traitements contre le cancer
• Se spécialiser dans les approches de traitement personnalisé

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Spécialisée en virothérapie – l'un des domaines les plus récents de l'immunologie – le Dr Jaunalksne apporte plus de 30 ans d'expérience au traitement du cancer du foie.

• Chef du Centre d'immunologie clinique de l'Hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur les approches immunologiques de pointe contre le cancer

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.